Contact information
| mina.davoudianfar@phc.ox.ac.uk | |
| Tel | +44 (0)1865 289336 |
Mina Davoudianfar
BA
Clinical Trial Manager
I joined the Nuffield Department of Primary Care Health Sciences in April 2013 . My role is to set-up, manage and deliver clinical trials at GP practices. The projects that I am currently working on are as follows:
HEAT- A large randomised controlled trial designed to investigate whether a one week course of H. pylori eradication will reduce the incidence of gastric ulcer bleeding in patients using aspirin ≤325mg daily.
EXPERT- A randomised controlled trial which forms part of the NIHR programme ‘Examining the role of patients’ experiences as a resource for choice and decision-making in health care’. The trial forms part of a programme of work which began in 2010 and aims to find out whether, when and how the NHS should incorporate people’s experiences into on-line health information.
POWeR2- A behavioural study to estimate the effectiveness of an internet based behavioural intervention with face-to-face support and remote support among obese patients in primary care.
Prior to my current role, I was working in Oncology Clinical Trials Office (Department of Oncology) for six years, working on different phase III randomised cancer trials.
Recent Publications
5-
Randomised controlled trial and economic analysis of an internet-based weight management programme: POWeR+ (Positive Online Weight Reduction)
Little P. et al, (2017), Health Technology Assessment, 21, 1 - 61
-
Randomised feasibility study of a novel experience-based internet intervention to support self-management in chronic asthma
Newhouse N. et al, (2016), BMJ Open, 6
-
A novel experience-based internet intervention for smoking cessation: feasibility randomised controlled trial
Powell J. et al, (2016), BMC Public Health, 16, 1 - 9
-
An internet-based intervention with brief nurse support to manage obesity in primary care (POWeR+): a pragmatic, parallel-group, randomised controlled trial
Little P. et al, (2016), The Lancet Diabetes and Endocrinology, 4, 821 - 828
-
Gefitinib for oesophageal cancer progressing after chemotherapy (COG): A phase 3, multicentre, double-blind, placebo-controlled randomised trial
Dutton SJ. et al, (2014), The Lancet Oncology, 15, 894 - 904